Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04608409
Recruitment Status : Recruiting
First Posted : October 29, 2020
Last Update Posted : December 8, 2020
Sponsor:
Information provided by (Responsible Party):
Frederick R. Ueland, M.D., University of Kentucky

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2025
Estimated Study Completion Date : June 30, 2025